NO995909L - Krystallinske makrolider og fremgangsmåte for deres fremstilling - Google Patents

Krystallinske makrolider og fremgangsmåte for deres fremstilling

Info

Publication number
NO995909L
NO995909L NO995909A NO995909A NO995909L NO 995909 L NO995909 L NO 995909L NO 995909 A NO995909 A NO 995909A NO 995909 A NO995909 A NO 995909A NO 995909 L NO995909 L NO 995909L
Authority
NO
Norway
Prior art keywords
preparation
macrolides
crystalline
crystalline macrolides
Prior art date
Application number
NO995909A
Other languages
English (en)
Other versions
NO995909D0 (no
NO312765B1 (no
Inventor
Cornelia Dosenbach
Maximillan Grassberger
Otto Hartmann
Amarylla Horvath
Jean-Paul Mutz
Sabine Pfeffer
Dierk Wiechusen
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10815103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO995909(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO995909D0 publication Critical patent/NO995909D0/no
Publication of NO995909L publication Critical patent/NO995909L/no
Publication of NO312765B1 publication Critical patent/NO312765B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19995909A 1997-06-30 1999-12-02 Krystallinske makrolider, fremgangsmåte for deres fremstilling, farmasöytiske sammensetninger inneholdende disse oganvendelsen av makrolidene NO312765B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9713730.1A GB9713730D0 (en) 1997-06-30 1997-06-30 Organic compounds
PCT/EP1998/003929 WO1999001458A1 (en) 1997-06-30 1998-06-26 Crystalline macrolides and process for their preparation

Publications (3)

Publication Number Publication Date
NO995909D0 NO995909D0 (no) 1999-12-02
NO995909L true NO995909L (no) 1999-12-02
NO312765B1 NO312765B1 (no) 2002-07-01

Family

ID=10815103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19995909A NO312765B1 (no) 1997-06-30 1999-12-02 Krystallinske makrolider, fremgangsmåte for deres fremstilling, farmasöytiske sammensetninger inneholdende disse oganvendelsen av makrolidene

Country Status (31)

Country Link
US (1) US6423722B1 (no)
EP (1) EP0994880B1 (no)
JP (2) JP3880634B2 (no)
KR (1) KR100399765B1 (no)
CN (1) CN1139595C (no)
AR (1) AR017754A1 (no)
AT (1) ATE287410T1 (no)
AU (1) AU739211B2 (no)
BR (1) BR9810956A (no)
CA (1) CA2290412C (no)
CO (1) CO4940463A1 (no)
CZ (1) CZ297244B6 (no)
DE (1) DE69828692T2 (no)
DK (1) DK0994880T3 (no)
ES (1) ES2236922T3 (no)
GB (1) GB9713730D0 (no)
HU (1) HU227755B1 (no)
ID (1) ID24897A (no)
IL (1) IL132761A0 (no)
MY (1) MY118718A (no)
NO (1) NO312765B1 (no)
NZ (1) NZ500994A (no)
PE (1) PE97699A1 (no)
PL (1) PL192761B1 (no)
PT (1) PT994880E (no)
RU (1) RU2219181C2 (no)
SK (1) SK285665B6 (no)
TR (1) TR199903189T2 (no)
TW (1) TW552264B (no)
WO (1) WO1999001458A1 (no)
ZA (1) ZA985655B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
GB9826656D0 (en) 1998-12-03 1999-01-27 Novartis Ag Organic compounds
GB0125443D0 (en) * 2001-10-23 2001-12-12 Novartis Ag Organic Compounds
EP2181995A3 (en) * 2003-09-03 2010-06-16 Glaxo Group Limited Salts and crystalline form of mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-yl-sufanyl)-acetate
AU2005230401B2 (en) * 2004-04-08 2008-11-27 Meda Pharma S.A.R.L. Pimecrolimus foam composition containing hexylene glycol, optionally oleyl alcohol, dimethylisosorbide and/or medium chain triglycerides
CA2584358A1 (en) 2004-12-01 2006-06-08 Teva Gyogyszergyar Zartkoeruen Mukoedo Reszvenytarsasag Non-hygroscopic and powdery amorphous pimecrolimus
TW200837067A (en) * 2006-11-06 2008-09-16 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of desmethylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
EP2944332B1 (en) 2009-07-10 2016-08-17 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
EP2453938B1 (en) 2009-07-17 2015-08-19 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
EP2611476B1 (en) 2010-09-02 2016-08-10 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
WO2013022458A1 (en) * 2011-08-05 2013-02-14 Boston Scientific Scimed, Inc. Methods of converting amorphous drug substance into crystalline form
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2014145780A1 (en) 2013-03-15 2014-09-18 Biosensors International Group, Ltd. Purification of rapamycin derivatives
EP3178824A1 (en) 2015-12-08 2017-06-14 Medichem, S.A. Process for preparing pimecrolimus
WO2018202733A1 (en) * 2017-05-01 2018-11-08 Meda Pharma Gmbh & Co. Kg Process to convert crude ascomycin into purified pimecrolimus
EP3741367A1 (en) 2019-05-21 2020-11-25 Premark Pharma GmbH Treatment of ocular disease
EP4687895A1 (en) 2023-04-06 2026-02-11 Premark Pharma GmbH Use of pimecrolimus for the treatment of dry eye in patients characterized by a corneal staining score of 4 or 5 on the oxford grading scale

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118816A (en) * 1975-04-08 1976-10-19 Meiji Seika Kaisha Ltd A process for stabilizing non-crystalloidal solid
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
CY1306A (en) 1980-10-01 1985-12-06 Glaxo Group Ltd Aminoalkyl furan derivative
JP2728482B2 (ja) * 1989-01-26 1998-03-18 協和醗酵工業株式会社 マクロライド系抗生物質の精製法
ES2023560A6 (es) 1989-07-10 1992-01-16 Gema Sa Procedimiento para la produccion de hidrato de cefradina y solvato de cefradina y dimetilformamida.
DK0427680T3 (da) * 1989-11-09 1995-12-18 Sandoz Ltd Heteroatom-holdige cykliske forbindelser
EP0594600A1 (en) * 1990-03-13 1994-05-04 FISONS plc Immunosuppressive macrocyclic compounds
EP0480623A1 (en) * 1990-10-11 1992-04-15 Merck & Co. Inc. New halomacrolides and derivatives having immunosuppressive activity
US5143918A (en) * 1990-10-11 1992-09-01 Merck & Co., Inc. Halomacrolides and derivatives having immunosuppressive activity
DE10199058I2 (de) 1991-07-30 2006-04-27 Alcm Co Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
US5247076A (en) 1991-09-09 1993-09-21 Merck & Co., Inc. Imidazolidyl macrolides having immunosuppressive activity
US5221740A (en) 1992-01-16 1993-06-22 American Home Products Corporation Oxepane isomers of rapamycin useful as immunosuppressive agents
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
US5626757A (en) * 1994-02-22 1997-05-06 Advanced Separation Technologies Inc. Macrocyclic antibiotics as separation agents
CA2229718A1 (en) * 1995-08-24 1997-03-06 David J. Mathre Process for the preparation of imidazolyl macrolide immunosuppressants
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds

Also Published As

Publication number Publication date
KR100399765B1 (ko) 2003-09-29
EP0994880A1 (en) 2000-04-26
JP4504323B2 (ja) 2010-07-14
ID24897A (id) 2000-08-31
AR017754A1 (es) 2001-10-24
KR20010020423A (ko) 2001-03-15
CO4940463A1 (es) 2000-07-24
PT994880E (pt) 2005-06-30
HUP0003053A3 (en) 2003-03-28
SK285665B6 (sk) 2007-05-03
JP2001506279A (ja) 2001-05-15
CA2290412A1 (en) 1999-01-14
NZ500994A (en) 2001-08-31
PL192761B1 (pl) 2006-12-29
CZ474099A3 (cs) 2000-04-12
CN1139595C (zh) 2004-02-25
ATE287410T1 (de) 2005-02-15
CA2290412C (en) 2009-11-10
PL336719A1 (en) 2000-07-03
TW552264B (en) 2003-09-11
EP0994880B1 (en) 2005-01-19
BR9810956A (pt) 2000-09-26
ES2236922T3 (es) 2005-07-16
WO1999001458A1 (en) 1999-01-14
RU2219181C2 (ru) 2003-12-20
CZ297244B6 (cs) 2006-10-11
IL132761A0 (en) 2001-03-19
DE69828692T2 (de) 2006-01-12
AU8540998A (en) 1999-01-25
NO995909D0 (no) 1999-12-02
MY118718A (en) 2005-01-31
SK186699A3 (en) 2000-05-16
HUP0003053A2 (hu) 2001-02-28
TR199903189T2 (xx) 2000-06-21
CN1261365A (zh) 2000-07-26
GB9713730D0 (en) 1997-09-03
NO312765B1 (no) 2002-07-01
DK0994880T3 (da) 2005-05-30
ZA985655B (en) 1998-12-30
AU739211B2 (en) 2001-10-04
DE69828692D1 (de) 2005-02-24
JP3880634B2 (ja) 2007-02-14
HU227755B1 (en) 2012-02-28
HK1028597A1 (en) 2001-02-23
JP2006151999A (ja) 2006-06-15
US6423722B1 (en) 2002-07-23
PE97699A1 (es) 1999-10-29

Similar Documents

Publication Publication Date Title
DK0909327T3 (da) Erythromyciner og fremgangsmåder til deres fremstilling
DK0985697T3 (da) Oxiranderivater og fremgangsmåde til fremstilling deraf
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
NO985196L (no) Dispergerbare makromolekylblandinger og fremgangsmÕter for deres fremstilli
ATE310742T1 (de) C-4ß-SUBSTITUTIERTE MACROLID-DERIVATE
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
DK0811006T3 (da) Benzopyranholdige forbindelser og fremgangsmåde til deres anvendelse
NO20000627D0 (no) ForhÕndsbelagte kontrollert - frigjørings - gjødningsmidler og fremgangsmÕter for deres fremstilling
NO995063L (no) Preparat med forsinket frigjöring og fremgangsmåter for deres fremstilling
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
HUP0100420A3 (en) Novel macrolides and process for preparing them
PL341647A1 (en) Novel derivatives of erythromycin
IS5251A (is) 9-oxím erýþrómýsín afleiður
NO20004896D0 (no) Pyridazinonhydrokloridforbindelse og fremgangsmÕte for fremstilling derav
IL132761A0 (en) Crystalline macrolides and process for their preparation
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
PL340290A1 (en) 2-halogeno-6-0-substituted derivatives of ketolide
NO943794D0 (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
DK1001684T3 (da) Afvandede kartoffelstykker og fremgangsmåde til deres fremstilling
NO985248D0 (no) Indolylpyrrolydenmetylpyrrolderivater og fremgangsmÕte for deres fremstilling
NO305804B1 (no) Krystallinsk maltitolblanding og fremstilling derav
DE69714228D1 (de) Kristalline metallophosphate
NO941517L (no) 2-amino-4-kinolin-dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
ID26418A (id) METODA KRISTALISASI ANTIBIOTIK β-LAKTAM
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired